Advertisement

Topics

In Turnaround Saga, Ignyta Nears Crucial Phase in Cancer Drug Trial

04:40 EDT 23 Sep 2016 | Xconomy

Biotech CEO Jonathan Lim co-founded Ignyta in 2011 to commercialize a new approach to diagnosing and treating rheumatoid arthritis, based on discoveries that showed how changes in methyl group molecules associated with the human genome could change the way genes function. Instead, Lim may end up showing how to breathe new life into a life […]

Original Article: In Turnaround Saga, Ignyta Nears Crucial Phase in Cancer Drug Trial

NEXT ARTICLE

More From BioPortfolio on "In Turnaround Saga, Ignyta Nears Crucial Phase in Cancer Drug Trial"

Quick Search
Advertisement
 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...